Global X ETFs ICAV shareholder notification

GLOBAL X ETFs ICAV

(an umbrella fund with segregated liability between sub-funds)

10 Earlsfort Terrace

Dublin 2 D02 T380

Ireland

This document is important and requires your immediate attention. If you are in any doubt as to the action you should take, you should seek advice from your investment consultant or other professional advisors.

This document has not been reviewed by the Central Bank of Ireland (the "Central Bank").

If you have sold or transferred all of your shares in Global X Hydrogen UCITS ETF please pass this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.

Capitalised terms used herein shall bear the same meaning as defined in the prospectus of Global X ETFs ICAV (the "ICAV") dated 6 May 2021, as amended by addenda thereto dated 13 May 2022 and 1 December 2022 respectively, (collectively, the "Prospectus") and the supplement to the Prospectus for the purpose of offering shares in Global X Hydrogen UCITS ETF, dated 1 December 2022 (the "Supplement"). Copies of the Prospectus and Supplement are available upon request during normal business hours from the registered office of the ICAV.

9 May 2023

RE: Global X Hydrogen UCITS ETF (the "Fund") - changes to the methodology of the Fund's index

Dear Investors,

The ICAV is an open-ended investment vehicle with variable capital organised under the laws of Ireland and is authorised by the Central Bank pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, as amended. The Fund is a sub-fund of the ICAV.

The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Global Hydrogen v2 Index (the "Index").

The Index provider has updated the methodology of the Index (the "Methodology"), including for the purpose of:

(a) including additional factors for determining the weight of selected components of the Index in advance of a rebalance of the Index, which takes place on a semi-annual basis;

(b) relaxing the market capitalisation and average daily traded volume liquidity criteria applicable to the components of the Index;

(c) increasing the maximum weight of a component of the Index, from 12% to 15%; and

                                                                                                                                                                                                                                                                                                                                                MI208/001/AC#46399445.4

Registered Office: as above

Registration Number: C435449

Directors: Mr. Feargal Dempsey, Ms. Mary Canning and Mr. Luis Berruga (USA)

(d) reflecting that the Index may be re-weighted outside the semi-annual rebalance dates reflected in the Methodology, on a "review day" (as defined in the Methodology), in circumstances where the administrator of the Index determines that any component of the Index exceeds a weight of 16%, so that the weight of the relevant component will be capped at 15%

(collectively, the "Index Methodology Updates").

The Metholdogy is available at: https://www.solactive.com/indices/?index=DE000SL0D1P6

The Supplement is proposed to be updated accordingly, in order to reflect the Index Methodology Updates. The updates to the Supplement will take effect on, or around, 26 May 2023, subject to the approval of the Central Bank.

Should you have any questions relating to the changes detailed above, you should contact your local agent, or (if none) Global X ETFs on +44 (0)20 4529 2551 or [email protected], or alternatively you should contact your investment consultant, tax adviser and/or legal adviser as appropriate.

Yours faithfully,

_______________

Director

For and on behalf of

Global X ETFs ICAV